Molecular characterization of HIV type 1 strains from newly diagnosed patients in Cyprus (2007-2009) recovers multiple clades including unique recombinant strains and lack of transmitted drug resistance

AIDS Research and Human Retroviruses

Volumn 27, Issue 11, 2011, Pages 1183-1199

  Kousiappa, Ioanna ^a   Achilleos, Charis ^a   Hezka, Johana ^a   Lazarou, Yiota ^a   Othonos, Katerina ^a   Demetriades, Ioannis ^b   Kostrikis, Leondios G ^a  

^a UNIVERSITY OF CYPRUS   (Cyprus)

^b Larnaca General Hospital   (Cyprus)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRASE; INTEGRASE INHIBITOR; PROTEINASE; PROTEINASE INHIBITOR; RNA DIRECTED DNA POLYMERASE; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ADULT; ARTICLE; CLINICAL FEATURE; CYPRUS; DATA BASE; DRUG RESISTANCE; FEMALE; GENE SEQUENCE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS 1; HUMAN IMMUNODEFICIENCY VIRUS 1 INFECTION; MAJOR CLINICAL STUDY; MALE; MOSAICISM; NONHUMAN; NUCLEOTIDE SEQUENCE; PHYLOGENY; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; VIRUS STRAIN;

ADULT; ANTI-HIV AGENTS; CHILD; CYPRUS; DRUG RESISTANCE, VIRAL; FEMALE; GENETIC VARIATION; HIV INFECTIONS; HIV-1; HUMANS; MALE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; MOLECULAR SEQUENCE DATA; MUTATION; PHYLOGENY; RECOMBINATION, GENETIC; SEQUENCE ANALYSIS, DNA;

EID: 80655125187     PISSN: 08892229     EISSN: 19318405     Source Type: Journal    
DOI: 10.1089/aid.2011.0060     Document Type: Article

References (44)

1. Ramirez BC, Simon-Loriere E, Galetto R, and Negroni M: Implications of recombination for HIV diversity. Virus Res 2008;134:64-73.
2. Robertson DL, Sharp PM, McCutchan FE, and Hahn BH: Recombination in HIV-1. Nature 1995;374:124-126.
3. Roberts JD, Bebenek K, and Kunkel TA: The accuracy of reverse transcriptase from HIV-1. Science 1988;242:1171-1173. (Pubitemid 19007043)
4. Plantier JC, Leoz M, Dickerson JE, De Oliveira F, Cordonnier F, Lemee V, et al.: A new human immunodeficiency virus derived from gorillas. Nat Med 2009;15:871-872.
5. Robertson DL, Anderson JP, Bradac JA, Carr JK, Foley B, Funkhouser RK, et al.: HIV-1 nomenclature proposal. Science 2000;288:55-56.
6. Leitner T, Korber B, Daniels M, Calef C, and Foley B: HIV-1 Subtype and Circulating Recombinant Form (CRF) Reference Sequences, 2005. Los Alamos National Laboratory, Los Alamos, NM, 2005.
7. Thomson MM and Najera R: Molecular epidemiology of HIV-1 variants in the global AIDS pandemic: An update. AIDS Rev 2005;7:210-224. (Pubitemid 43115953)
8. The Circulating Recombinant Forms (CRFs): Los Alamos National Laboratory (online), http://www.hiv.lanl.gov (last modified: Tuesday January 26, 10:10, 2010).
9. de Silva TI, Turner R, Hue S, Trikha R, van Tienen C, Onyango C, et al.: HIV-1 subtype distribution in the Gambia and the significant presence of CRF49-cpx, a novel circulating recombinant form. Retrovirology 2010;7:82.
10. Chew CB, Herring BL, Zheng F, Browne C, Saksena NK, Cunningham AL, et al.: Comparison of three commercial assays for the quantification of HIV-1 RNA in plasma from individuals infected with different HIV-1 subtypes. J Clin Virol 1999;14:87-94. (Pubitemid 29512205)
11. Gottesman BS, Grossman Z, Lorber M, Levi I, Shitrit P, Katzir M, et al.: Comparative performance of the Amplicor HIV-1 Monitor Assay versus NucliSens EasyQ in HIV subtype C-infected patients. J Med Virol 2006;78:883-887. (Pubitemid 43856694)
12. Rolland M, Nickle DC, and Mullins JI: HIV-1 group M conserved elements vaccine. PLoS Pathog 2007;3:e157.
13. Fischer W, Perkins S, Theiler J, Bhattacharya T, Yusim K, Funkhouser R, et al.: Polyvalent vaccines for optimal coverage of potential T-cell epitopes in global HIV-1 variants. Nat Med 2007;13:100-106. (Pubitemid 46067393)
14. Nickle DC, Rolland M, Jensen MA, Pond SL, Deng W, Se-ligman M, et al.: Coping with viral diversity in HIV vaccine design. PLoS Comput Biol 2007;3:e75.
15. Kostrikis LG, Bagdades E, Cao Y, Zhang L, Dimitriou D, and Ho DD: Genetic analysis of human immunodeficiency virus type 1 strains from patients in Cyprus: Identification of a new subtype designated subtype I. J Virol 1995;69:6122-6130.
16. Kousiappa I, van de Vijver DA, Demetriades I, and Kostrikis LG: Genetic analysis of HIV type 1 strains from newly infected untreated patients in Cyprus: High genetic diversity and low prevalence of drug resistance. AIDS Res Hum Retroviruses 2009;25:23-35.
17. Kousiappa I, Van De Vijver DA, and Kostrikis LG: Near full-length genetic analysis of HIV sequences derived from Cyprus: Evidence of a highly polyphyletic and evolving infection. AIDS Res Hum Retroviruses 2009;25: 727-740.
18. Vandamme AM, Sonnerborg A, Ait-Khaled M, Albert J, Asjo B, Bacheler L, et al.: Updated European recommendations for the clinical use of HIV drug resistance testing. Antivir Ther 2004;9:829-848. (Pubitemid 40040258)
19. Loizidou EZ, Kousiappa I, Zeinalipour-Yazdi CD, Van de Vijver DA, and Kostrikis LG: Implications of HIV-1 M group polymorphisms on integrase inhibitor efficacy and resistance: Genetic and structural in silico analyses. Biochemistry 2009;48:4-6.
20. Johnson VA, Brun-Vezinet F, Clotet B, Gunthard HF, Kur-itzkes DR, Pillay D, et al.: Update of the drug resistance mutations in HIV-1: 2007. Top HIV Med 2007;15:119-125.
21. Shafer RW: Rationale and uses of a public HIV drug-resistance database. J Infect Dis 2006;194(Suppl 1):S51-58 (Pubitemid 44420873)
22. Stanford HIV Resistance Database: Genotypic Resistance Interpretation Algorithm (HIVdb Program: Sequence Analysis). http://hivdb.stanford.edu.
23. Tamura K, Dudley J, Nei M, and Kumar S: MEGA4: Molecular Evolutionary Genetics Analysis (MEGA) software version 4.0. Mol Biol Evol 2007;24:1596-1599. (Pubitemid 47236692)
24. Los Alamos National Laboratory (online), http://www.hiv.lanl.gov (last modified: Tuesday January 26, 2010).
25. de Oliveira T, Deforche K, Cassol S, Salminen M, Paraskevis D, Seebregts C, et al.: An automated genotyping system for analysis of HIV-1 and other microbial sequences. Bioinformatics 2005;21:3797-3800. (Pubitemid 41535530)
26. Lole KS, Bollinger RC, Paranjape RS, Gadkari D, Kulkarni SS, Novak NG, et al.: Full-length human immunodeficiency virus type 1 genomes from subtype C-infected seroconverters in India, with evidence of intersubtype recombination. J Virol 1999;73:152-160. (Pubitemid 28565356)
27. Altschul SF, Gish W, Miller W, Myers EW, and Lipman DJ: Basic local alignment search tool. J Mol Biol 1990;215:403-410.
28. Available at http://www.hiv.lanl.gov/content/sequence/HIV/HIVTools.html.
29. Shafer RW and Schapiro JM: HIV-1 drug resistance mutations: An updated framework for the second decade of HAART. AIDS Rev 2008;10:67-84.
30. Carr JK, Wolfe ND, Torimiro JN, Tamoufe U, Mpoudi-Ngole E, Eyzaguirre L, et al.: HIV-1 recombinants with multiple parental strains in low-prevalence, remote regions of Cameroon: Evolutionary relics? Retrovirology 2010;7:39.
31. Machuca A, Tang S, Hu J, Lee S, Wood O, Vockley C, et al.: Increased genetic diversity and intersubtype recombinants of HIV-1 in blood donors from urban Cameroon. J Acquir Immune Defic Syndr 2007;45:361-363. (Pubitemid 47012387)
32. Liitsola K, Tashkinova I, Laukkanen T, Korovina G, Smols-kaja T, Momot O, et al.: HIV-1 genetic subtype A/B recom-binant strain causing an explosive epidemic in injecting drug users in Kaliningrad. AIDS 1998;12:1907-1919. (Pubitemid 28454457)
33. Magiorkinis G, Paraskevis D, Vandamme AM, Magiorkinis E, Sypsa V, and Hatzakis A: In vivo characteristics of human immunodeficiency virus type 1 intersubtype recombination: Determination of hot spots and correlation with sequence similarity. J Gen Virol 2003;84:2715-2722. (Pubitemid 37220249)
34. Fan J, Negroni M, and Robertson DL: The distribution of HIV-1 recombination breakpoints. Infect Genet Evol 2007;7:717-723. (Pubitemid 47629712)
35. Magiorkinis G, Paraskevis D, and Hatzakis A: Comments on "The distribution of HIV-1 recombination breakpoints" by Jun Fan, Matteo Negroni, David L. Robertson. Infect Genet Evol 2008;8:527-528.
36. McCutchan FE: Global epidemiology of HIV. J Med Virol 2006;78:S7-S12. (Pubitemid 43993457)
37. Kita K, Ndembi N, Ekwalanga M, Ido E, Kazadi R, Bi-kandou B, et al.: Genetic diversity of HIV type 1 in Likasi, southeast of the Democratic Republic of Congo. AIDS Res Hum Retroviruses 2004;20:1352-1357. (Pubitemid 40065931)
38. Vidal N, Mulanga C, Bazepeo SE, Mwamba JK, Tshimpaka JW, Kashi M, et al.: Distribution of HIV-1 variants in the Democratic Republic of Congo suggests increase of subtype C in Kinshasa between 1997 and 2002. J Acquir Immune Defic Syndr 2005;40:456-462. (Pubitemid 41669181)
39. Delgado E, Rios M, Fernandez J, Perez-Alvarez L, Najera R, and Thomson MM: Identification of a new HIV type 1 BF intersubtype circulating recombinant form (CRF44-BF) in Chile. AIDS Res Hum Retroviruses 2010;26:821-826.
40. Brennan CA, Bodelle P, Coffey R, Devare SG, Golden A, Hackett J Jr, et al.: The prevalence of diverse HIV-1 strains was stable in Cameroonian blood donors from 1996 to 2004. J Acquir Immune Defic Syndr 2008;49:432-439.
41. Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Ba-lotta C, Hamouda O, et al.: Transmission of drug-resistant HIV-1 is stabilizing in Europe. J Infect Dis 2009;200:1503-1508.
42. Papathanasopoulos MA, Hunt GM, and Tiemessen CT: Evolution and diversity of HIV-1 in Africa-a review. Virus Genes 2003;26:151-163. (Pubitemid 36656336)
43. Brennan CA, Bodelle P, Coffey R, Harris B, Holzmayer V, Luk KC, et al.: HIV global surveillance: Foundation for retroviral discovery and assay development. J Med Virol 2006;78:S24-S29. (Pubitemid 43993461)
44. Hirsch MS, Brun-Vezinet F, Clotet B, Conway B, Kuritzkes DR, D'Aquila RT, et al.: Antiretroviral drug resistance testing in adults infected with human immunodeficiency virus type 1: 2003 recommendations of an International AIDS Society-USA Panel. Clin Infect Dis 2003;37: 113-128 (Pubitemid 36836653)